Manufacturing Controlled Substances

Article

David Mayers, president of Wellspring Pharma Services sat down with Pharmaceutical Technology to discuss the manufacture of controlled substances. 

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Behind the Headlines, Episode 18
Behind the Headlines, Episode 17
Related Content
A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2

Feliza Mirasol
February 12th 2025
Article

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs.

Site Logo

Bringing Gene Therapies to Market

August 1st 2019
Article

Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.

Site Logo

Gene Therapy Production Must Pass Regulatory Hurdles

August 1st 2019
Article

Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.

Site Logo

CPhI 2016 Excellence in Pharma: Packaging Award Winner Interview

January 3rd 2017
Article

Pylote SA discusses its Pyclear Protection packaging innovation.

Site Logo

Improving Regulatory Compliance

December 1st 2016
Article

Andrew Bulpin, head of Process Solutions Strategic Marketing and Innovation, MilliporeSigma discusses the company's Emprove Program, winner of the 2016 CPhI Award for Regulatory Procedures and Compliance. 

Site Logo

Minitablets in Pharma Manufacturing

June 29th 2016
Article